Pharmacist roles in the management of patients with type 2 diabetes

被引:25
作者
Sisson, Evan
Kuhn, Catherine [1 ,2 ]
机构
[1] Med Univ S Carolina, S Carolina Coll Pharm, Dept Clin Pharm & Outcome Sci, Charleston, SC 29425 USA
[2] KDI Hlth Solut, N Charleston, SC USA
关键词
Pharmacists; diabetes clinic; diabetes education; incretins; GLP-1 receptor agonists; DPP-4; inhibitors; diabetes self-management education and training; CORONARY-HEART-DISEASE; CLINICAL-OUTCOMES; CARE; INTERVENTIONS; METAANALYSIS; MELLITUS; GLP-1; RISK;
D O I
10.1331/JAPhA.2009.09075
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To summarize the current and future roles of pharmacists in providing care to and educating patients with diabetes. Data sources: Review articles and studies describing the role, function, and impact of pharmacists participating in diabetes care and education were reviewed. A literature search was conducted in Medline (1996 to July 2008) using the search terms diabetes, pharmacist, and collaborative practice. Reference lists from comprehensive review articles were also used to identify additional original research publications. Study selection: By the authors. Data extraction: By the authors. Data synthesis: As the diabetes epidemic continues to grow, primary care providers may find their ability to respond to patient needs increasingly challenged. In the coming years, patients with diabetes will likely need to engage a team of educators, coaches, and specialists rather than a sole provider. The challenge for the patient education-treatment team will be effective communication and collaboration as the patient passes from one care level to the next. Well-educated, motivated patients benefit most from collaborating with a multidisciplinary patient care team that aggressively and systematically seeks to optimize clinical outcomes. Whether in the role of coach, educator, or direct-care provider, pharmacists are vital members of this interdisciplinary diabetes care team. Conclusion: With the increasing complexity of therapy regimens and overwhelming numbers of patients with type 2 diabetes, the pharmacist's role has expanded beyond dispensing medications, counseling on adverse effects, and monitoring for contraindications to include evaluation and initiation of new agents to optimize patient outcomes.
引用
收藏
页码:S41 / S45
页数:5
相关论文
共 33 条
[1]  
*AM PHARM ASS, 2004, DIAB MAN SERV PHARM
[2]  
[Anonymous], 2007, National Diabetes Fact Sheet
[3]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[4]   Pharmacist membership in a medical group's diabetes health management program [J].
Brooks, Amie D. ;
Rihani, Rami S. ;
Derus, Charles L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (06) :617-621
[5]   Fate of the beta-cell in the pathophysiology of type 2 diabetes [J].
Campbell, R. Keith .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 :S10-S15
[6]   Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006 [J].
Cheung, Bernard M. Y. ;
Ong, Kwok Leung ;
Cherny, Stacey S. ;
Sham, Pak-Chung ;
Tso, Annette W. K. ;
Lam, Karen S. L. .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (05) :443-453
[7]   Management of patients with type 2 diabetes by pharmacists in primary care clinics [J].
Coast-Senior, EA ;
Kroner, BA ;
Kelley, CL ;
Trilli, LE .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (06) :636-641
[8]  
Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P149, DOI 10.1331/108658003321480696
[9]  
Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P173, DOI 10.1331/108658003321480713
[10]  
FERA T, 2009, J AM PHARM ASSOC, pE52